
### [MONDO:0017594](http://purl.obolibrary.org/obo/MONDO_0017594)
**Label:** indolent b-cell non-Hodgkin lymphoma

**Subclasses:** [MONDO:0017600](http://purl.obolibrary.org/obo/MONDO_0017600) (hairy cell leukemia variant), [MONDO:0007190](http://purl.obolibrary.org/obo/MONDO_0007190) (leukemia, chronic lymphocytic, susceptibility to, 2), [MONDO:0017599](http://purl.obolibrary.org/obo/MONDO_0017599) (splenic diffuse red pulp small b-cell lymphoma), [MONDO:0019469](http://purl.obolibrary.org/obo/MONDO_0019469) (T-cell large granular lymphocyte leukemia), [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0018621](http://purl.obolibrary.org/obo/MONDO_0018621) (lymphoplasmacytic lymphoma without IgM production), [MONDO:0019465](http://purl.obolibrary.org/obo/MONDO_0019465) (Nodal marginal zone b-cell lymphoma), [MONDO:0013088](http://purl.obolibrary.org/obo/MONDO_0013088) (FL1), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0019462](http://purl.obolibrary.org/obo/MONDO_0019462) (splenic marginal zone lymphoma), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), [MONDO:0007897](http://purl.obolibrary.org/obo/MONDO_0007897) (leukemia, chronic lymphocytic), [MONDO:0012936](http://purl.obolibrary.org/obo/MONDO_0012936) (leukemia, chronic lymphocytic, susceptibility to, 5), [MONDO:0015819](http://purl.obolibrary.org/obo/MONDO_0015819) (indolent primary cutaneous b-cell lymphoma), [MONDO:0007650](http://purl.obolibrary.org/obo/MONDO_0007650) (malt lymphoma), [MONDO:0015814](http://purl.obolibrary.org/obo/MONDO_0015814) (primary cutaneous follicle center lymphoma), [MONDO:0018906](http://purl.obolibrary.org/obo/MONDO_0018906) (follicular lymphoma), [MONDO:0017604](http://purl.obolibrary.org/obo/MONDO_0017604) (marginal zone lymphoma), [MONDO:0012935](http://purl.obolibrary.org/obo/MONDO_0012935) (leukemia, chronic lymphocytic, susceptibility to, 4), [MONDO:0012318](http://purl.obolibrary.org/obo/MONDO_0012318) (leukemia, chronic lymphocytic, susceptibility to, 1), [MONDO:0012934](http://purl.obolibrary.org/obo/MONDO_0012934) (leukemia, chronic lymphocytic, susceptibility to, 3), [MONDO:0015813](http://purl.obolibrary.org/obo/MONDO_0015813) (primary cutaneous marginal zone b-cell lymphoma), [MONDO:0018935](http://purl.obolibrary.org/obo/MONDO_0018935) (hairy cell leukemia), 

**Corr. equiv. classes:** [Orphanet:300869](http://www.orpha.net/ORDO/Orphanet_300869), [Orphanet:33226](http://www.orpha.net/ORDO/Orphanet_33226), [Orphanet:86854](http://www.orpha.net/ORDO/Orphanet_86854), [Orphanet:178540](http://www.orpha.net/ORDO/Orphanet_178540), [Orphanet:86872](http://www.orpha.net/ORDO/Orphanet_86872), [OMIM:153600](http://purl.obolibrary.org/obo/OMIM_153600), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:613024](http://purl.obolibrary.org/obo/OMIM_613024), [OMIM:610430](http://purl.obolibrary.org/obo/OMIM_610430), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:58017](http://www.orpha.net/ORDO/Orphanet_58017), [Orphanet:178536](http://www.orpha.net/ORDO/Orphanet_178536), [OMIM:137245](http://purl.obolibrary.org/obo/OMIM_137245), [Orphanet:178557](http://www.orpha.net/ORDO/Orphanet_178557), [Orphanet:300912](http://www.orpha.net/ORDO/Orphanet_300912), [Orphanet:300878](http://www.orpha.net/ORDO/Orphanet_300878), [Orphanet:52417](http://www.orpha.net/ORDO/Orphanet_52417), [Orphanet:86867](http://www.orpha.net/ORDO/Orphanet_86867), [Orphanet:443159](http://www.orpha.net/ORDO/Orphanet_443159), [Orphanet:545](http://www.orpha.net/ORDO/Orphanet_545), 

**Class expressions from DL-Learner:**

- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000003](http://purl.obolibrary.org/obo/HP_0000003) (Multicystic kidney dysplasia))) 27.01%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 26.94%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000016](http://purl.obolibrary.org/obo/HP_0000016) (Urinary retention))) 26.94%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000013](http://purl.obolibrary.org/obo/HP_0000013) (Hypoplasia of the uterus))) 26.94%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000012](http://purl.obolibrary.org/obo/HP_0000012) (Urinary urgency))) 26.94%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000011](http://purl.obolibrary.org/obo/HP_0000011) (Neurogenic bladder))) 26.94%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) and (not ([HP:0000004](http://purl.obolibrary.org/obo/HP_0000004) (null))) 26.94%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 23.87%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 23.66%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 20.79%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 20.56%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 19.70%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 17.44%
- Thing 17.44%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 17.44%


